Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.

Despierre, Evelyn; Vergote, Ignace; Anderson, Ryan; Coens, Corneel; Katsaros, Dionyssios; Hirsch, Fred R; Boeckx, Bram; Varella-Garcia, Marileila; Ferrero, Annamaria; Ray-Coquard, Isabelle; Berns, Els M J J; Casado, Antonio; Lambrechts, Diether; Jimeno, Antonio

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/21811

Title:	Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.
Authors:	Despierre, Evelyn Vergote, Ignace Anderson, Ryan Coens, Corneel Katsaros, Dionyssios Hirsch, Fred R Boeckx, Bram Varella-Garcia, Marileila Ferrero, Annamaria Ray-Coquard, Isabelle Berns, Els M J J Casado, Antonio Lambrechts, Diether Jimeno, Antonio View more
Mesh:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Biomarkers, Tumor Disease Progression Disease-Free Survival ErbB Receptors Erlotinib Hydrochloride Female Humans Middle Aged Mutation Organoplatinum Compounds Ovarian Neoplasms Protein Kinase Inhibitors Protein Kinases View more
Issue Date:	Dec-2015
Citation:	Target Oncol.2015 Dec;(10)4:583-96
Abstract:	In this work, we aimed to identify molecular epidermal growth factor receptor (EGFR) tissue biomarkers in patients with ovarian cancer who were treated within the phase III randomized European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) 55041 study comparing erlotinib with observation in patients with no evidence of disease progression after first-line platinum-based chemotherapy.
PMID:	26004768
URI:	https://hdl.handle.net/20.500.12530/21811
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:

File	Description	Size	Format
PMC4661131.pdf		1.06 MB	Adobe PDF	View/Open

Show full item record